R&D研发中心
- Genesis obtained the registration certification of RSV /ADV Antigen Rapid test kits
- Geneis participate in AACC meeting at Chicago
- Genesis participate in the 63rd China International Medical Equipment Fair(CMEF 2010 Spring)
- Genesis participate American Association of Clinical Chemistry's (AACC)
- Exhibition Information 2013
- Geneis participate in Düsseldorf Messe MEDICA – International Trade Fair & Congress for Medicine
- GENESIS Launched Mycoplasma Pneumoniae
Antigen Rapid Diagnostic Test Kit - Genesis’ Sales & Marketing Center was launched
- Paper: Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay
- Overview of Influenza Surveillance in China
- Collection of Technical Documents for Chinese National Influenza Center
- Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
- China's new WHO flu monitoring center seeks to reverse criticism
- No child should die of TB.
- Tuberculosis is a global pandemic
- XDR-TB has been confirmed in more than 100 countries around the world
- Efforts to contain the spread of the tenacious form of TB have proven insufficient, and HIV clinics and hospitals have become the most likely source of infectio
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.(Abbreviation: Genesis) specialized in invitro diagnostic reagents development, production and sales of high-tech pharmaceutical enterprises, post-doctoral workstations.
Genesis has a strong research and development team and advanced technical innovation ability, under the leadership of Chinese-American scientist, focusing on quality and innovation in vitro diagnostic reagent products, we are committed to accelerate the rapid development of the biomedical industry, providing performance for the biomedical field superior products and technical services.
Genesis has been continuously developed a variety of respiratory and gastrointestinal diseases new road system diseases, by used to the four core technology platform, including GICA technology, Reverse immunochromatographic technology and Immunofluorescence technology platform , Microbial culture detection technology, Plastics engineering technology. Influenza A / influenza B virus antigen detection kit (colloidal gold), respiratory syncytial virus antigen detection kit (colloidal gold) and Mycobacterium tuberculosis antigen detection kit (colloidal gold) are the first to obtain the corresponding production approval in the country.
Now Genesis has respiratory products, digestive on hundreds of products, food testing, etc., by self-development, domestic and international technical cooperation, to meet our customers specialized, personalized one-stop service needs.Product line covers GICA technology, microbial culture detection technology, immunofluorescence techniques, engineering plastics technology, standards, and laboratory equipment, supplies, etc., welcome people from all walks of life to come to cooperation projects, processing, personalized production.
Genesis established offices in several provinces to facilitate customer orders, timely feedback customer information. Sales staff, technical staff and cooperative enterprises in the art together form a more comprehensive nationwide after sales service system to ensure that customers all kinds of information, the demand can be timely feedback, and help the company provide customers with timely technical support.
Users can search the site by product of interest, or browse through product list on the left side of this page. GENESIS has Key Features are listed by title to help Users, and customers can quickly lock products.
Genesis has a strong research and development team and advanced technical innovation ability, under the leadership of Chinese-American scientist, focusing on quality and innovation in vitro diagnostic reagent products. we are committed to accelerate the rapid development of the biomedical industry, providing performance for the biomedical field superior products and technical services. Genesis use to the four core technology platform, and launched research services related to the platform as follows:
1. GICA technology platform
2. Microbial culture detection technology platform
3.Immunofluorescence technology platform
4. Nucleic acid detection technology platform
5. Reverse immunochromatographic technology platform
6. Plastics engineering technology Platform
7. Antigen recombinant genetic engineering technology research
8. Monoclonal antibody screening techniques monoclonal antibody research
9. Materials research and development
10. OEM, plastic mold opening service